Incyte Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Portfolio Pulse from Benzinga Insights
Incyte (NASDAQ:INCY) has been analyzed by 9 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $67.11, up 3.07% from the previous target. Analysts have adjusted their ratings and price targets, reflecting their views on Incyte's market performance. Despite a 9.34% revenue growth, Incyte's financial metrics like net margin, ROE, and ROA are below industry averages, indicating challenges in profitability and asset utilization.
September 03, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Incyte's stock has been analyzed by 9 analysts, showing mixed ratings. The average price target increased by 3.07% to $67.11. Despite revenue growth, financial metrics like net margin, ROE, and ROA are below industry averages, indicating challenges in profitability and asset utilization.
The mixed analyst ratings and slight increase in price target suggest a neutral short-term impact on Incyte's stock. While revenue growth is positive, the below-average financial metrics may offset potential gains, leading to a balanced outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100